AAAAI 2021: Dupilumab is Beneficial for Severe Atopic Dermatitis in Children Regardless of Asthma
Similar benefits were observed at two different dupilumab doses
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.